340 related articles for article (PubMed ID: 24247144)
1. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.
Nguyen ST; Kwasny SM; Ding X; Cardinale SC; McCarthy CT; Kim HS; Nikaido H; Peet NP; Williams JD; Bowlin TL; Opperman TJ
Bioorg Med Chem; 2015 May; 23(9):2024-34. PubMed ID: 25818767
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.
Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H
Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.
Aron Z; Opperman TJ
Curr Opin Microbiol; 2016 Oct; 33():1-6. PubMed ID: 27232955
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Sonnet P; Izard D; Mullié C
Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
[TBL] [Abstract][Full Text] [Related]
7. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
[TBL] [Abstract][Full Text] [Related]
8. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
Zhou X; Jia F; Liu X; Wang Y
Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
[TBL] [Abstract][Full Text] [Related]
10. The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach.
Abdel-Halim H; Al Dajani A; Abdelhalim A; Abdelmalek S
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6309-6318. PubMed ID: 31209525
[TBL] [Abstract][Full Text] [Related]
11. Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.
Bohnert JA; Schuster S; Kern WV; Karcz T; Olejarz A; Kaczor A; Handzlik J; Kieć-Kononowicz K
Antimicrob Agents Chemother; 2016 Apr; 60(4):1974-83. PubMed ID: 26824939
[TBL] [Abstract][Full Text] [Related]
12. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
[TBL] [Abstract][Full Text] [Related]
13. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
[TBL] [Abstract][Full Text] [Related]
14. A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in
Tambat R; Mahey N; Chandal N; Verma DK; Jangra M; Thakur KG; Nandanwar H
ACS Infect Dis; 2022 Feb; 8(2):255-270. PubMed ID: 35045260
[TBL] [Abstract][Full Text] [Related]
15. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
[TBL] [Abstract][Full Text] [Related]
16. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
17. AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity
Sturge CR; Felder-Scott CF; Pifer R; Pybus C; Jain R; Geller BL; Greenberg DE
ACS Infect Dis; 2019 Aug; 5(8):1446-1455. PubMed ID: 31119935
[TBL] [Abstract][Full Text] [Related]
18. Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.
Saw HT; Webber MA; Mushtaq S; Woodford N; Piddock LJ
J Antimicrob Chemother; 2016 Jun; 71(6):1510-9. PubMed ID: 26945714
[TBL] [Abstract][Full Text] [Related]
19. [Bacterial efflux pumps - their role in antibiotic resistance and potential inhibitors].
Hricová K; Kolář M
Klin Mikrobiol Infekc Lek; 2014 Dec; 20(4):116-20. PubMed ID: 25702054
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae.
Weston N; Sharma P; Ricci V; Piddock LJV
Res Microbiol; 2018; 169(7-8):425-431. PubMed ID: 29128373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
